These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8383377)
41. Seroprevalence to cytomegalovirus in the Portuguese population, 2002-2003. Lopo S; Vinagre E; Palminha P; Paixao MT; Nogueira P; Freitas MG Euro Surveill; 2011 Jun; 16(25):. PubMed ID: 21722611 [TBL] [Abstract][Full Text] [Related]
42. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion. Ziemann M; Krueger S; Maier AB; Unmack A; Goerg S; Hennig H Transfusion; 2007 Nov; 47(11):1972-83. PubMed ID: 17958525 [TBL] [Abstract][Full Text] [Related]
43. Optimal prevention of transfusion-transmitted cytomegalovirus (TTCMV) infection by modern leukocyte reduction alone: CMV sero/antibody-negative donors needed only for leukocyte products. Strauss RG Transfusion; 2016 Aug; 56(8):1921-4. PubMed ID: 27500914 [No Abstract] [Full Text] [Related]
44. CMV mismatch does not affect patient and graft survival in UK renal transplant recipients. Johnson RJ; Clatworthy MR; Birch R; Hammad A; Bradley JA Transplantation; 2009 Jul; 88(1):77-82. PubMed ID: 19584684 [TBL] [Abstract][Full Text] [Related]
45. Transfusion-related cytomegalovirus infection among very low birth weight infants in an endemic area. Kim AR; Lee YK; Kim KA; Chu YK; Baik BY; Kim ES; Yun SC; Kim KS; Pi SY J Korean Med Sci; 2006 Feb; 21(1):5-10. PubMed ID: 16479056 [TBL] [Abstract][Full Text] [Related]
46. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?]. Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432 [TBL] [Abstract][Full Text] [Related]
47. Cytomegalovirus (CMV) antibody in male homosexuals: a source for CMV immune globulin. Ikram H; Prince AM; Baker LN Vox Sang; 1983 Mar; 44(3):173-7. PubMed ID: 6301160 [TBL] [Abstract][Full Text] [Related]
48. Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters. van Prooijen HC; Visser JJ; van Oostendorp WR; de Gast GC; Verdonck LF Br J Haematol; 1994 May; 87(1):144-7. PubMed ID: 7947238 [TBL] [Abstract][Full Text] [Related]
49. [Experiences with a "rapid test" in detecting antibodies to cytomegalovirus]. Milbradt H Klin Wochenschr; 1989 Aug; 67(16):839-40. PubMed ID: 2552223 [TBL] [Abstract][Full Text] [Related]
50. Transmission of cytomegalovirus (CMV) infection by leukoreduced blood products not tested for CMV antibodies: a single-center prospective study in high-risk patients undergoing allogeneic hematopoietic stem cell transplantation (CME). Thiele T; Krüger W; Zimmermann K; Ittermann T; Wessel A; Steinmetz I; Dölken G; Greinacher A Transfusion; 2011 Dec; 51(12):2620-6. PubMed ID: 21645009 [TBL] [Abstract][Full Text] [Related]
51. Transfusion- and community-acquired cytomegalovirus infection in children with malignant disease: a prospective study. Preiksaitis JK; Desai S; Vaudry W; Roberts S; Akabutu J; Grundy P; Wilson B; Boshkov L; Hannon J; Joffres M Transfusion; 1997 Sep; 37(9):941-6. PubMed ID: 9308642 [TBL] [Abstract][Full Text] [Related]
52. [Persistence of antibodies of the IgG class against cytomegaloviruses in blood donors]. Eichler C; Kaden J; Blauärmel O; Zimmermann G; Adamczyk G Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):560-9. PubMed ID: 2446998 [TBL] [Abstract][Full Text] [Related]
53. Determination of cytomegalovirus antibody titers in sera of volunteer blood donors by use of complement fixation and two immunoenzymatic tests. Dzierzanowska D; Kołodziejczyk J; Lourie I Arch Immunol Ther Exp (Warsz); 1986; 34(4):397-402. PubMed ID: 3026277 [TBL] [Abstract][Full Text] [Related]
54. Safety of filtered leukocyte-reduced blood products for prevention of transfusion-associated cytomegalovirus infection. Landaw EM; Kanter M; Petz LD Blood; 1996 Jun; 87(11):4910. PubMed ID: 8639866 [No Abstract] [Full Text] [Related]
55. Thalassemic patients are at high risk for transfusion-transmitted cytomegalovirus infections. Germenis A; Politis C Acta Haematol; 1989; 82(2):57-60. PubMed ID: 2552729 [TBL] [Abstract][Full Text] [Related]
56. Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potency. Albano MS; Ciubotariu R; Dobrila L; Tarnawski M; DeLeon M; Watanabe C; Krishnan S; Scaradavou A; Rubinstein P Transfusion; 2017 Nov; 57(11):2768-2774. PubMed ID: 28758211 [TBL] [Abstract][Full Text] [Related]